-
Potency of antibodies generated against chikungunya infection was higher during patients' recovery phase than that during their acute infection phase.
-
In the new paper, published by iScience, antibodies extracted from 800 year-old medieval human teeth were found to be stable and still able to recognise viral proteins
-
Hyderabad: In general, an antibody test (serological test) for Covid-19 is performed in specialized labs, and to get results it takes anywhere from 24 hours to several days. But a new paper test developed by researchers from the Massachusetts Institute of Technology (MIT) has shown that it takes only 10 minutes to find the level of neutralizing antibodies […]
-
By Dr. Modala Mallesh Hyderabad: This article is in continuation of the previous articles that help you understand what constitutes the biological sciences and its varied branches/ concepts. Today, we would be discussing the fifth part of the Biomedical technology with a focus on Enzyme-linked immunosorbent assay (ELISA). ELISA (Enzyme-linked immunosorbent assay) ELISA is […]
-
New York: Getting sick with a common cold doesn’t make you immune to Covid-19, but a Covid infection might, at least temporarily, boost the number of antibodies you have against common cold-causing coronaviruses and the SARS-CoV-1 and MERS-CoV viruses, all of which are closely related, finds a study.A Scientists at Scripps Research in California have characterised […]
-
New York: Around 90 minutes of mild- to moderate-intensity exercise directly after the flu or the Covid-19 vaccine may provide an extra immune boost, suggests a new study. The study showed that participants who cycled on a stationary bike or took a brisk walk for an hour-and-a-half after getting a jab produced more antibodies in […]
-
For the study, the researchers mined published papers about Covid-19 patients for data about the sequence of the antibodies they produced.
-
A study by researchers at the Barcelona Institute for Global Health (ISGlobal), found that people who were infected by SARS-CoV-2, the virus causing Covid-19, had lower levels of HCoV antibodies
-
Researchers from the University of Padua (Italy) and the Imperial College London tested more than 85 per cent of the 3,000 residents of Vo' in Italy, in February/March 2020 for infection with SARS-CoV-2
-
Lower antibody count after jab does not mean poor immunity, say experts
-
Members of the Foundation presented demonstrations by holding placards at Telangana Chowk
-
The team from the University of Texas at Austin analysed blood plasma samples from four people who recovered from SARS-CoV-2 infections.
-
The small study, published in the American Journal of Obstetrics and Gynaecology, analysed the blood of 27 pregnant women who had received either the Pfizer or Moderna vaccine in their third trimester
-
The woman, who has been breastfeeding the baby exclusively, received the second dose of the vaccine as per the normal 28-day vaccination protocol timeline.
-
"We were able to leverage the unique high-throughput capacity that was already in place and apply it to SARS-CoV-2," said researcher Alejandro Balazs from Massachusetts General Hospital in the US.
-
The study showed that 54 per cent of the population in the city has antibodies, which means they have developed immunity to SARS-CoV-2 virus
-
The sero-prevalence at the national level went up 3.1 times between August and December but in Telangana, this went up by two times
-
We utilized the latest advances in materials and manufacturing such as nanoparticle 3D printing to create a device that rapidly detects Covid-19 antibodies," said researcher Rahul Panat, Associate Professor at Carnegie Mellon
-
The findings which were published in Science Immunology identifies new links between the course of the disease and a patient's immune response to it
-
The results of the study also revealed that antibodies were not only in sufficient numbers, but also strong, when the plasma was donated within 12-53 days post recovery.